Table 5 Frozen-thawed embryo transfer and pregnancy outcomes of the study patients
Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | ||||
|---|---|---|---|---|---|---|---|---|
GnRH-a administration | Triptorelin 3.75 mg | Triptorelin 3.75 mg, twice | Triptorelin 3.75 mg | Triptorelin 3.75 mg | Triptorelin 1.87 mg | Triptorelin 3.75 mg | Leuprorelin 3.75 | None |
Glucocorticoid | DXM 0.375 mg/d | DXM 0.375 mg/d | DXM 0.75 mg/d | DXM 0.75 mg/d | DXM 0.75 mg/d | DXM 0.75 mg/d | DXM 0.75 mg/d | DXM 0.75 mg/d |
Duration of estradiol valerate administration, days | 11 | 9 | 10 | 15 | 12 | 12 | 11 | 14 |
Endometrial thickness on transformation day, mm | 7.8 | 8.2 | 11.2 | 9.0 | 12.1 | 12.0 | 17.0 | 11.9 |
E2 on transformation day, ng/L | None | None | 221 | 220 | 114 | 309 | 177 | 261 |
P on transformation day, ng/ml | None | 0.18 | 3.10 | 0.21 | < 0.1 | < 0.1 | < 0.1 | 0.22 |
Number of embryo transferred | 2 | 2 | 2 | 3 | 2 | 1 | 2 | 2 |
Pregnancy outcome | Singleton pre-term live birth, vaginal delivery. | No pregnancy | No pregnancy | Singleton pre-term live birth, caesarean section. | No pregnancy | Biochemical pregnancy | Singleton full-term live birth, caesarean section. | Singleton full-term live birth, caesarean section. |